SEC Form 4 · accession 0001609351-16-000027
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Altschuler
Director
Period of report
Apr 27, 2016
Accepted (ET)
Apr 29, 2016 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 27, 2016 | A | 20,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F133% vests on July 1, 2016 and the remainder vests annually over the following two years.